Switzerland

Geneva’s Spineart raises CHF 25M to accelerate global growth in advanced spine surgery
Geneva-based medtech company Spineart has secured a CHF 25M capital increase, backed by long-term investors Gimv and EGS Beteiligungen (EGSB).

The best Articles in our Network